![Lori Lyons-Williams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lori Lyons-Williams
Directeur/Membre du Conseil chez
CONTINEUM THERAPEUTICS, INC.
Fortune : - $ au 31/07/2026
Profil
Lori M.
Lyons-Williams is President, Chief Executive Officer & Director at Abdera Therapeutics, Inc. since 2022.
Holds the position of Vice Chairman at the National Association for Continence.
Serves as Independent Director at Contineum Therapeutics, Inc. since 2020.
Formerly Chairman at Rapt Therapeutics, Inc. from 2025 to 2026.
Independent Director at Five Prime Therapeutics, Inc. from 2019 to 2021.
Director at Girls, Inc. Chief Commercial Officer at Dermira, Inc. from 2016 to 2020.
President & Chief Operating Officer at Neumora Therapeutics, Inc. from 2020 to 2022.
Vice President-Sales & Marketing at Allergan, Inc. from 2002 to 2016.
Educated at Virginia Polytechnic Institute & State University (undergraduate) and The Curtis L.
Carlson School of Management (MBA).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Lori Lyons-Williams
| Sociétés | Poste | Début |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/08/2020 |
National Association for Continence
 National Association for Continence Miscellaneous Commercial ServicesCommercial Services Provides continence care through education, collaboration and advocacy | Directeur/Membre du Conseil | - |
Abdera Therapeutics, Inc.
 Abdera Therapeutics, Inc. Packaged SoftwareTechnology Services Develops precision radiotherapeutics platform | Directeur Général | 01/05/2022 |
Anciens postes connus de Lori Lyons-Williams
| Sociétés | Poste | Fin |
|---|---|---|
| RAPT THERAPEUTICS, INC. | Président | 03/03/2026 |
| NEUMORA THERAPEUTICS, INC. | President | 01/04/2022 |
| FIVE PRIME THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/04/2021 |
| DERMIRA, INC. | Corporate Officer/Principal | 01/05/2020 |
| ALLERGAN, INC. | Sales & Marketing | 01/08/2016 |
Formation de Lori Lyons-Williams
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Virginia Polytechnic Institute & State University
 Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Girls, Inc.
 Girls, Inc. Miscellaneous Commercial ServicesCommercial Services Provides educational programs for girls | Commercial Services |
National Association for Continence
National Association for Continence Miscellaneous Commercial ServicesCommercial Services Provides continence care through education, collaboration and advocacy | Commercial Services |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
The Curtis L. Carlson School of Management
 The Curtis L. Carlson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rapt Therapeutics, Inc.
 Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. Packaged SoftwareTechnology Services Develops precision radiotherapeutics platform | Technology Services |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
